Enzastaurin
- Generic Name
- Enzastaurin
- Drug Type
- Small Molecule
- Chemical Formula
- C32H29N5O2
- CAS Number
- 170364-57-5
- Unique Ingredient Identifier
- UC96G28EQF
Overview
Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer.
Background
Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer.
Indication
Investigated for use/treatment in brain cancer, lymphoma (non-hodgkin's), and lung cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath